Kent Leyde

Title: Kent Leyde: Innovator in Epilepsy Treatment Technologies

Introduction

Kent Leyde is a notable inventor based in Redmond, WA (US). He has made significant contributions to the field of medical technology, particularly in the treatment of epilepsy. His innovative approach focuses on utilizing quantified biomarkers to enhance therapy systems.

Latest Patents

Kent Leyde holds a patent for "Therapy systems with quantified biomarker targeting, including for epilepsy treatment, and associated systems and methods." This patent describes a computer-based method for establishing epilepsy treatment parameters for patients. The method involves receiving multiple indications of interictal EEG biomarkers over a period of time and processing these indications to produce a processed biomarker. This processed biomarker is then used to identify target locations in the patient's brain for delivering electrical therapy signals aimed at reducing or eliminating epileptic activity.

Career Highlights

Throughout his career, Kent Leyde has worked with prominent organizations such as Cadence Neuroscience, Inc. and the Mayo Foundation for Medical Education and Research. His experience in these institutions has allowed him to develop and refine his innovative ideas in the medical technology sector.

Collaborations

Kent has collaborated with various professionals in his field, including his coworker Brian Lundstrom. Their joint efforts have contributed to advancements in epilepsy treatment technologies.

Conclusion

Kent Leyde's work in developing therapy systems for epilepsy treatment showcases his commitment to innovation in medical technology. His contributions are paving the way for more effective treatment options for patients suffering from epilepsy.